Showing results (101-110 of 190) with videos related to

Sort By:
Pageof 19
Inorganic Chemistry|August 31, 2010
NMR spectroscopic evidence for the intermediacy of XeF(3)(-) in XeF(2)/F(-) exchange, attempted syntheses and thermochemistry of XeF(3)(-) salts, and theoretical studies of the XeF(3)(-) anionNeil Vasdev, Matthew D Moran, Heikki M Tuononen, et al.
Chemical Communications (Cambridge, England)|December 6, 2016
Metal-free 18F-labeling of aryl-CF2H via nucleophilic radiofluorination and oxidative C-H activationGengyang Yuan, Feng Wang, Nickeisha A Stephenson, et al.
Synapse (New York, N.Y.)|June 21, 2006
Radiosynthesis, ex vivo and in vivo evaluation of [11C]preclamol as a partial dopamine D2 agonist radioligand for positron emission tomographyNeil Vasdev, Sridhar Natesan, Laurent Galineau, et al.
Chemical Communications (Cambridge, England)|May 16, 2013
11CO2 fixation: a renaissance in PET radiochemistryBenjamin H Rotstein, Steven H Liang, Jason P Holland, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Leveraging Open Science Drug Development for PET: Preliminary Neuroimaging of 11C-Labeled ALK2 InhibitorsEmily Murrell, Junchao Tong, David Smil, et al.
Bioorganic & Medicinal Chemistry Letters|December 10, 2014
Radiosynthesis and ex vivo evaluation of [(18)F]-(S)-3-(6-(3-fluoropropoxy)benzo[d]isoxazol-3-yl)-5-(methoxymethyl)oxazolidin-2-one for imaging MAO-B with PETJustin W Hicks, Oleg Sadovski, Jun Parkes, et al.
Molecular Pharmaceutics|July 9, 2014
PET imaging of fatty acid amide hydrolase with [(18)F]DOPP in nonhuman primatesBenjamin H Rotstein, Hsiao-Ying Wey, Timothy M Shoup, et al.
ACS Chemical Neuroscience|June 25, 2020
Classics in Neuroimaging: Development of Positron Emission Tomography Tracers for Imaging the GABAergic PathwayEmily Murrell, Jonathan M Pham, Alexandra R Sowa, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2019
Synthesis and preclinical evaluation of [18F]FSL25.1188, a reversible PET radioligand for monoamine oxidase-BKenneth Dahl, Vadim Bernard-Gauthier, Sangram Nag, et al.
Bioorganic & Medicinal Chemistry|March 19, 2008
Rationally designed PKA inhibitors for positron emission tomography: Synthesis and cerebral biodistribution of N-(2-(4-bromocinnamylamino)ethyl)-N-[11C]methyl-isoquinoline-5-sulfonamideNeil Vasdev, Frank J LaRonde, James R Woodgett, et al.
Pageof 19